A Phase I Trial to Evaluate the Safety of IMC002 in Advanced Digestive System Tumors

NCT05946226 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Digestive System Tumor

Interventions

BIOLOGICAL: IMC002 injection

Sponsor

Suzhou Immunofoco Biotechnology Co., Ltd